We would handle the action on a contingent fee basis, whereby you would not be responsible for out of pocket payment of our legal fees or expenses.
DECA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF DENALI CAPITAL ACQUISITION CORP. IS FAIR TO SHAREHOLDERS
September 3, 2024.
New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Denali Capital Acquisition Corp. (NASDAQ: DECA) and Semnur Pharmaceuticals, Inc. is fair to Denali shareholders. The proposed transaction provides for a pre-transaction equity value of Semnur at $2.5 billion.
The investigation concerns whether Denali and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Denali shareholders; and (2) disclose all material information necessary for Denali shareholders to adequately assess and value the merger consideration.
On behalf of Denali shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.